Company Profiles

driven by the PitchBook Platform

Remedy Pharmaceuticals

Description

Developer of small molecule drugs. The company has developed a drug CIRARA, that target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes and spinal cord injuries.

2005

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$9M

Latest Deal Amount

$15.3M

Total Amount Raised

Description

Developer of small molecule drugs. The company has developed a drug CIRARA, that target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes and spinal cord injuries.

Website:

www.remedypharmaceuticals.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

122 West 27th Street 10th Floor New York, NY 10001United States +1 (212) 586-2226
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Remedy Pharmaceuticals's full profile, request a free trial.

Remedy Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Remedy Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Remedy Pharmaceuticals Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Biosciences Research and Commercialization CenterVenture CapitalMinority000 0000000 0000
Broadview VenturesVenture CapitalMinority000 0000000 0000
Carrot Capital Healthcare VenturesVenture CapitalMinority000 0000000 0000
New Ground VenturesVenture CapitalMinority000 0000000 0000
The Vertical GroupVenture CapitalMinority000 0000000 0000
Biosciences Research and Commercialization Center Venture Capital
Broadview Ventures Venture Capital
Carrot Capital Healthcare Ventures Venture Capital
New Ground Ventures Venture Capital
The Vertical Group Venture Capital

Remedy Pharmaceuticals Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Richard SteinhartChief Financial Officer & Vice President
Thomas MacAllister JDVice President, Research & Development & General Counsel
Sven JacobsonCo-Founder, Chief Executive Officer & Board Member
Richard Steinhart Chief Financial Officer & Vice President
Thomas MacAllister JD Vice President, Research & Development & General Counsel
Sven Jacobson Co-Founder, Chief Executive Officer & Board Member

Remedy Pharmaceuticals Board Members (6)

NameRepresentingRoleSinceContact
Info
Charles MeleSelfBoard Member & Advisor000 0000
David GeliebterCarrot Capital Healthcare VenturesManaging Director & Senior Partner000 0000
Eric PottsRemedy PharmaceuticalsBoard Observer000 0000
Frederick Jones MDBroadview VenturesDirector000 0000
Kurt LandgrafSelfBoard Member000 0000
Charles Mele Board Member & Advisor Self
David Geliebter Managing Director & Senior Partner Carrot Capital Healthcare Ventures
Eric Potts Board Observer Remedy Pharmaceuticals
Frederick Jones MD Director Broadview Ventures
Kurt Landgraf Board Member Self
Request full access to PitchBook